Browse drugs

…lone and plasma exchange in intensive care and was commenced on natalizumab but deteriorated with a further reduction in level of conscious…

…term consequences and significant risk of longer-term morbidity.Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor, u…

…Following a multidisciplinary discussion, immunotherapy such as rituximab was deferred, and a haematology referral was made due to invest…

…at least once prescribed reimbursed medication—glucocorticoids (prednisolone or methylprednisolone), conventional synthetic disease-modifyin…

…actory to multiple therapies including rituximab, belimumab and obinutuzumab. The patient was treated under single-patient IND (#30146) with…

…pproximately 15% remain refractory to all treatment modalities. Rituximab, mycophenolate mofetil and cyclophosphamide are of therapeutic …

…ubsequently developed meningococcal sepsis after treatment with ravulizumab, despite prior vaccination; and we propose strategies to manage…

…sclerosis. 3 days after receiving her first dose of intravenous Ig, she developed a pruritic rash in her intertriginous regions of…

…ICT clearance), rituximab (anti-CD20 for B-cell depletion), and infliximab (anti-TNF-a for T-cell and potential myeloid suppression). We h…

…responses were associated with favorable clinical outcomes with ipilimumab.4 Tertiary lymphoid structures (TLS) are aggregates of T cells,…

…F-β individually, in both FaDu and 4T1 tumor models.Conclusions HCB301 represents a novel therapeutic approach that simultaneously tar…

…y in evaluating ADCC antibodies like Trastuzumab, Margetuximab, Rituximab and Blinatumomab. Collectively, the NCG-hIL2 and NCG-hIL15 mode…